A new class of photoswitchable small molecule drugs has been developed to restore key visual functions in animal models of blindness. These compounds mimic the function of photoreceptor cells and show remarkable effectiveness at restoring sight using a simple and potentially patient-friendly approach.
SourceInstitute for Bioengineering of Catalonia (IBEC)·JournalJournal of the American Chemical Society·TypeExperimental study·DateJul 15, 2026
A study has identified a gene, RANBP1, that appears to play a significant role in raising the risk of severe subtypes of autism and other genetic diseases. The findings suggest that disruptions in brain signaling networks may be good targets for future research and potentially lead to new treatment opportunities.
SourceChildren's Hospital of Philadelphia·JournalScientific Reports·DateJan 19, 2016